Outcomes of dasatinib plus intensive chemotherapy or stem cell transplant (SCT) for Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) on Children’s Oncology Group AALL0622.
Year: 2015
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: William Birdsall Slayton, John A Kairalla, Kirk R. Schultz, Meenakshi Devidas, Shanjun Helian, Michael Pulsipher, Bill H. Chang, William L. Carroll, Michael J. Borowitz, Valerie I. Brown, Naomi J. Winick, Andrew J Carroll, Nyla A. Heerema, Julie M Gastier-Foster, Brent L. Wood, Sherri L. Mizrahy, Stephen Hunger
Institutions: University of Florida, BC Children's Hospital, Children's Oncology Group, University of Utah, Doernbecher Children's Hospital, NYU Langone Health, Johns Hopkins University, Pennsylvania State University, Penn State Milton S. Hershey Medical Center, The University of Texas Southwestern Medical Center, The Ohio State University Wexner Medical Center, Nationwide Children's Hospital, University of Washington, Children's Hospital of Philadelphia
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2595546087
